Telomere length changes in patients undergoing hematopoietic stem cell transplantation

Area of Science:

• Cellular Biology
• Hematology
• Genetics

Background:

• Telomere length is a key indicator of cellular replicative history and potential.
• Hematopoietic stem cell transplantation (HSCT) involves the transfer of stem cells to restore blood and immune function.
• Understanding telomere dynamics post-HSCT is crucial for assessing long-term cellular health and potential complications.

Purpose of the Study:

• To investigate and quantify telomere length changes in hematopoietic stem cells following different types of HSCT.
• To compare telomere lengths in recipients of allogeneic bone marrow transplantation (allo-BMT) and autologous peripheral blood stem cell transplantation (auto-PBSCT) with healthy controls.

Main Methods:

• Study included 15 patients in the allo-BMT group, 7 in the auto-PBSCT group, and 39 healthy controls.
• Telomere length was measured in peripheral blood mononuclear cells using Southern blot hybridization.
• Statistical analysis was performed to compare telomere lengths between groups and correlate with clinical parameters.

Main Results:

• No significant difference in telomere length was found between the allo-BMT and auto-PBSCT groups.
• Recipients in the allo-BMT group exhibited significantly shorter telomeres compared to their donors and age-matched controls (equivalent to 41.4 and 52.4 years of aging, respectively).
• Recipients in the auto-PBSCT group also showed significantly shorter telomeres than age-matched controls (equivalent to 61.5 years of aging).

Conclusions:

• Hematopoietic stem cells undergo substantial telomere shortening after HSCT, irrespective of the transplant type.
• This telomere attrition suggests accelerated cellular aging and may be linked to an increased risk of clonal disorders later in life.
• A trend towards negative correlation between telomere shortening and the number of infused mononuclear cells was observed in the allo-BMT group.